Non-muscle invasive bladder cancer is cancer that’s only in the inner lining of your bladder. It hasn’t grown into the muscle wall. Your doctor may also call it superficial bladder cancer, urothelial ...

D Path, a company dedicated to personalizing cancer care through a novel, physics-inspired approach to predicting tumor response to therapy, today announced its participation as an exploratory ...

Source: Getty Images The 2025 EAU guidelines provide updated insights into risk factors, diagnosis, classification, treatment, and follow-up of patients with muscle-invasive and metastatic bladder ...

Perioperative management for muscle invasive bladder cancer (MIBC) includes neoadjuvant cisplatin-based chemotherapy (NAC) followed by radical cystectomy and risk-adapted adjuvant immunotherapy. More ...

Nearly 84,000 Americans will receive a bladder cancer diagnosis this year, yet most people remain unaware of the early warning signs that could save their lives. This silent disease often masquerades ...

Inlexzo is approved for BCG-unresponsive NMIBC with CIS, offering a new treatment option for patients with limited alternatives. The SunRISe-1 trial showed an 82% complete response rate, with 51% ...

Bladder Cancer e-Tumor Boards: Case 9: Metastatic Recurrent Urothelial Cancer This case highlights a patient who initially presented with an advanced stage upper tract urothelial tumor, and he ...

A 63-year-old man with a 20 pack-year smoking history but who quit 5 years earlier presented initially with gross hematuria. Computed tomography (CT) of the abdomen and pelvic with IV contrast was ...